Abstract
Vessels are not uniform tubes but are subdivided into arterial, venous, and lymphatic vessels. Large vessels (arteries, veins, large lymphatic trunks), medium-size vessels (arterioles, venules, medium-sized lymphatics), and capillaries are also distinguished. As we have just seen, the identification of the VEGF family had a considerable impact on both basic and clinical research (see below). Nevertheless, the simple picture that we had following Folkman’s work has become considerably more complicated and many modifications/corrections have been made at the cellular and molecular levels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163–1177. https://doi.org/10.1083/jcb.200302047
Gerhardt H, Betsholtz C (2005) How do endothelial cells orientate? EXS 94:3–15
Benedito R, Rocha SF, Woeste M, Zamykal M, Radtke F, Casanovas O, Duarte A, Pytowski B, Adams RH (2012) Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484(7392):110–114. https://doi.org/10.1038/nature10908
Zarkada G, Heinolainen K, Makinen T, Kubota Y, Alitalo K (2015) VEGFR3 does not sustain retinal angiogenesis without VEGFR2. Proc Natl Acad Sci U S A 112(3):761–766. https://doi.org/10.1073/pnas.1423278112
Tamariz E, Varela-Echavarria A (2015) The discovery of the growth cone and its influence on the study of axon guidance. Front Neuroanat 9:51. https://doi.org/10.3389/fnana.2015.00051
Pelton JC, Wright CE, Leitges M, Bautch VL (2014) Multiple endothelial cells constitute the tip of developing blood vessels and polarize to promote lumen formation. Development 141(21):4121–4126. https://doi.org/10.1242/dev.110296
Thomas JL, Baker K, Han J, Calvo C, Nurmi H, Eichmann AC, Alitalo K (2013) Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells. Cell Mol Life Sci 70(10):1779–1792. https://doi.org/10.1007/s00018-013-1312-6
Ochsenbein AM, Karaman S, Proulx ST, Berchtold M, Jurisic G, Stoeckli ET, Detmar M (2016) Endothelial cell-derived semaphorin 3A inhibits filopodia formation by blood vascular tip cells. Development 143(4):589–594. https://doi.org/10.1242/dev.127670
Teuwen LA, Draoui N, Dubois C, Carmeliet P (2017) Endothelial cell metabolism: an update anno 2017. Curr Opin Hematol. https://doi.org/10.1097/MOH.0000000000000335
Kur E, Kim J, Tata A, Comin CH, Harrington KI, Costa Lda F, Bentley K, Gu C (2016) Temporal modulation of collective cell behavior controls vascular network topology. eLife 5. https://doi.org/10.7554/eLife.13212
Sigurbjornsdottir S, Mathew R, Leptin M (2014) Molecular mechanisms of de novo lumen formation. Nat Rev Mol Cell Biol 15(10):665–676. https://doi.org/10.1038/nrm3871
Strilic B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara N, Lammert E (2009) The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 17(4):505–515. https://doi.org/10.1016/j.devcel.2009.08.011
Kucera T, Strilic B, Regener K, Schubert M, Laudet V, Lammert E (2009) Ancestral vascular lumen formation via basal cell surfaces. PLoS One 4(1):e4132. https://doi.org/10.1371/journal.pone.0004132
Kamei M, Saunders WB, Bayless KJ, Dye L, Davis GE, Weinstein BM (2006) Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 442(7101):453–456. https://doi.org/10.1038/nature04923
Herwig L, Blum Y, Krudewig A, Ellertsdottir E, Lenard A, Belting HG, Affolter M (2011) Distinct cellular mechanisms of blood vessel fusion in the zebrafish embryo. Curr Biol 21(22):1942–1948. https://doi.org/10.1016/j.cub.2011.10.016
Axnick J, Lammert E (2012) Vascular lumen formation. Curr Opin Hematol 19(3):192–198. https://doi.org/10.1097/MOH.0b013e3283523ebc
Phng LK, Gebala V, Bentley K, Philippides A, Wacker A, Mathivet T, Sauteur L, Stanchi F, Belting HG, Affolter M, Gerhardt H (2015) Formin-mediated actin polymerization at endothelial junctions is required for vessel lumen formation and stabilization. Dev Cell 32(1):123–132. https://doi.org/10.1016/j.devcel.2014.11.017
Gebala V, Collins R, Geudens I, Phng LK, Gerhardt H (2016) Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo. Nat Cell Biol 18(4):443–450. https://doi.org/10.1038/ncb3320
Yang Y, Oliver G (2014) Development of the mammalian lymphatic vasculature. J Clin Invest 124(3):888–897. https://doi.org/10.1172/JCI71609
Sabine A, Agalarov Y, Maby-El Hajjami H, Jaquet M, Hagerling R, Pollmann C, Bebber D, Pfenniger A, Miura N, Dormond O, Calmes JM, Adams RH, Makinen T, Kiefer F, Kwak BR, Petrova TV (2012) Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell 22(2):430–445. https://doi.org/10.1016/j.devcel.2011.12.020
Trani M, Dejana E (2015) New insights in the control of vascular permeability: vascular endothelial-cadherin and other players. Curr Opin Hematol. https://doi.org/10.1097/MOH.0000000000000137
Le Guelte A, Dwyer J, Gavard J (2011) Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer. Biol Cell 103(12):593–605. https://doi.org/10.1042/BC20110069
Azzi S, Hebda JK, Gavard J (2013) Vascular permeability and drug delivery in cancers. Front Oncol 3:211. https://doi.org/10.3389/fonc.2013.00211
Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15(7):1751
Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chretien M, Seidah NG, Khatib AM (2003) The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 111(11):1723–1732. https://doi.org/10.1172/JCI17220
Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M, Autiero M, Wyns S, Plaisance S, Moons L, van Rooijen N, Giacca M, Stassen JM, Dewerchin M, Collen D, Carmeliet P (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131(3):463–475. https://doi.org/10.1016/j.cell.2007.08.038
Dewerchin M, Carmeliet P (2014) Placental growth factor in cancer. Expert Opin Ther Targets 18(11):1339–1354. https://doi.org/10.1517/14728222.2014.948420
Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P, Cao Y (2002) Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 1(1):99–108
Yang X, Zhang Y, Yang Y, Lim S, Cao Z, Rak J, Cao Y (2013) Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth. Proc Natl Acad Sci U S A 110(34):13932–13937. https://doi.org/10.1073/pnas.1309629110
Davis S, Yancopoulos GD (1999) The angiopoietins: Yin and Yang in angiogenesis. Curr Top Microbiol Immunol 237:173–185
Koh GY (2013) Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 19(1):31–39. https://doi.org/10.1016/j.molmed.2012.10.010
Auguste P, Gursel DB, Lemiere S, Reimers D, Cuevas P, Carceller F, Di Santo JP, Bikfalvi A (2001) Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res 61(4):1717–1726
Larrieu-Lahargue F, Welm AL, Bouchecareilh M, Alitalo K, Li DY, Bikfalvi A, Auguste P (2012) Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis. PLoS One 7(6):e39540. https://doi.org/10.1371/journal.pone.0039540
Shin JW, Min M, Larrieu-Lahargue F, Canron X, Kunstfeld R, Nguyen L, Henderson JE, Bikfalvi A, Detmar M, Hong YK (2006) Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17(2):576–584. https://doi.org/10.1091/mbc.E05-04-0368
Rousseau B, Larrieu-Lahargue F, Javerzat S, Guilhem-Ducleon F, Beermann F, Bikfalvi A (2004) The tyrp1-Tag/tyrp1-FGFR1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blockade of fibroblast growth factor receptor activity. Cancer Res 64(7):2490–2495
Casanovas O, Hicklin DJ, Bergers G, Hanahan D (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8(4):299–309. https://doi.org/10.1016/j.ccr.2005.09.005
Murakami M, Nguyen LT, Zhuang ZW, Moodie KL, Carmeliet P, Stan RV, Simons M (2008) The FGF system has a key role in regulating vascular integrity. J Clin Invest 118(10):3355–3366. https://doi.org/10.1172/JCI35298
De Smet F, Tembuyser B, Lenard A, Claes F, Zhang J, Michielsen C, Van Schepdael A, Herbert JM, Bono F, Affolter M, Dewerchin M, Carmeliet P (2014) Fibroblast growth factor signaling affects vascular outgrowth and is required for the maintenance of blood vessel integrity. Chem Biol 21(10):1310–1317. https://doi.org/10.1016/j.chembiol.2014.07.018
Yu P, Wilhelm K, Dubrac A, Tung JK, Alves TC, Fang JS, Xie Y, Zhu J, Chen Z, De Smet F, Zhang J, Jin SW, Sun L, Sun H, Kibbey RG, Hirschi KK, Hay N, Carmeliet P, Chittenden TW, Eichmann A, Potente M, Simons M (2017) FGF-dependent metabolic control of vascular development. Nature 545(7653):224–228. https://doi.org/10.1038/nature22322
Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314(1):15–23. https://doi.org/10.1007/s00441-003-0745-x
Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C (2003) Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17(15):1835–1840. https://doi.org/10.1101/gad.266803
Gaengel K, Genove G, Armulik A, Betsholtz C (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29(5):630–638. https://doi.org/10.1161/ATVBAHA.107.161521
Ferrara N (2010) Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis. Curr Opin Hematol 17(3):219–224. https://doi.org/10.1097/MOH.0b013e3283386660
Chung AS, Wu X, Zhuang G, Ngu H, Kasman I, Zhang J, Vernes JM, Jiang Z, Meng YG, Peale FV, Ouyang W, Ferrara N (2013) An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med 19(9):1114–1123. https://doi.org/10.1038/nm.3291
Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W, Morrisey EE, McMahon AP, Karsenty G, Lang RA (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437(7057):417–421. https://doi.org/10.1038/nature03928
Stefater JA III, Lewkowich I, Rao S, Mariggi G, Carpenter AC, Burr AR, Fan J, Ajima R, Molkentin JD, Williams BO, Wills-Karp M, Pollard JW, Yamaguchi T, Ferrara N, Gerhardt H, Lang RA (2011) Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 474(7352):511–515. https://doi.org/10.1038/nature10085
Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496(7446):445–455. https://doi.org/10.1038/nature12034
Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM (2014) Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 17(1):109–118. https://doi.org/10.1007/s10456-013-9381-6
Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, Garner H, Trouillet C, de Bruijn MF, Geissmann F, Rodewald HR (2015) Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518(7540):547–551. https://doi.org/10.1038/nature13989
Rymo SF, Gerhardt H, Wolfhagen Sand F, Lang R, Uv A, Betsholtz C (2011) A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One 6(1):e15846. https://doi.org/10.1371/journal.pone.0015846
Zhang F, Li Y, Tang Z, Kumar A, Lee C, Zhang L, Zhu C, Klotzsche-von Ameln A, Wang B, Gao Z, Zhang S, Langer HF, Hou X, Jensen L, Ma W, Wong W, Chavakis T, Liu Y, Cao Y, Li X (2012) Proliferative and survival effects of PUMA promote angiogenesis. Cell Rep 2(5):1272–1285. https://doi.org/10.1016/j.celrep.2012.09.023
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3):353–364
Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33(4):207–214. https://doi.org/10.1016/j.tips.2012.01.005
Kaelin WG Jr, Ratcliffe PJ (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30(4):393–402. https://doi.org/10.1016/j.molcel.2008.04.009
Berra E, Pages G, Pouyssegur J (2000) MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 19(1–2):139–145
Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38(9):1060–1065. https://doi.org/10.1038/ng1855
Shibuya M (2013) VEGFR and type-V RTK activation and signaling. Cold Spring Harb Perspect Biol 5(10):a009092. https://doi.org/10.1101/cshperspect.a009092
Lampropoulou A, Ruhrberg C (2014) Neuropilin regulation of angiogenesis. Biochem Soc Trans 42(6):1623–1628. https://doi.org/10.1042/BST20140244
Murakami M, Simons M (2008) Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol 15(3):215–220. https://doi.org/10.1097/MOH.0b013e3282f97d98
Hawinkels LJ, Garcia de Vinuesa A, Ten Dijke P (2013) Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy. Expert Opin Investig Drugs 22(11):1371–1383. https://doi.org/10.1517/13543784.2013.837884
Freitas C, Larrivee B, Eichmann A (2008) Netrins and UNC5 receptors in angiogenesis. Angiogenesis 11(1):23–29. https://doi.org/10.1007/s10456-008-9096-2
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314
Warburg O (1956) On respiratory impairment in cancer cells. Science 124(3215):269–270
Verdegem D, Moens S, Stapor P, Carmeliet P (2014) Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab 2:19. https://doi.org/10.1186/2049-3002-2-19
Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, Zecchin A, Cantelmo AR, Christen S, Goveia J, Heggermont W, Godde L, Vinckier S, Van Veldhoven PP, Eelen G, Schoonjans L, Gerhardt H, Dewerchin M, Baes M, De Bock K, Ghesquiere B, Lunt SY, Fendt SM, Carmeliet P (2015) Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520(7546):192–197. https://doi.org/10.1038/nature14362
Lazarus A, Del-Moral PM, Ilovich O, Mishani E, Warburton D, Keshet E (2011) A perfusion-independent role of blood vessels in determining branching stereotypy of lung airways. Development 138(11):2359–2368. https://doi.org/10.1242/dev.060723
Magenheim J, Ilovich O, Lazarus A, Klochendler A, Ziv O, Werman R, Hija A, Cleaver O, Mishani E, Keshet E, Dor Y (2011) Blood vessels restrain pancreas branching, differentiation and growth. Development 138(21):4743–4752. https://doi.org/10.1242/dev.066548
Lammert E, Cleaver O, Melton D (2003) Role of endothelial cells in early pancreas and liver development. Mech Dev 120(1):59–64
Lammert E, Gu G, McLaughlin M, Brown D, Brekken R, Murtaugh LC, Gerber HP, Ferrara N, Melton DA (2003) Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 13(12):1070–1074
Rafii S, Butler JM, Ding BS (2016) Angiocrine functions of organ-specific endothelial cells. Nature 529(7586):316–325. https://doi.org/10.1038/nature17040
Kim J, Kang Y, Kojima Y, Lighthouse JK, Hu X, Aldred MA, McLean DL, Park H, Comhair SA, Greif DM, Erzurum SC, Chun HJ (2013) An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med 19(1):74–82. https://doi.org/10.1038/nm.3040
Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, Upton PD, Crosby A, Sawiak SJ, Carpenter TA, Glen RC, Morrell NW, Maguire JJ, Davenport AP (2017) Elabela/toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 135(12):1160–1173. https://doi.org/10.1161/CIRCULATIONAHA.116.023218
de Jesus Perez V, Yuan K, Alastalo TP, Spiekerkoetter E, Rabinovitch M (2014) Targeting the Wnt signaling pathways in pulmonary arterial hypertension. Drug Discov Today 19(8):1270–1276. https://doi.org/10.1016/j.drudis.2014.06.014
Fan Y, Potdar AA, Gong Y, Eswarappa SM, Donnola S, Lathia JD, Hambardzumyan D, Rich JN, Fox PL (2014) Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1alpha accumulation. Nat Cell Biol 16(5):445–456. https://doi.org/10.1038/ncb2954
Cao Z, Ding BS, Guo P, Lee SB, Butler JM, Casey SC, Simons M, Tam W, Felsher DW, Shido K, Rafii A, Scandura JM, Rafii S (2014) Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell 25(3):350–365. https://doi.org/10.1016/j.ccr.2014.02.005
Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6(6):553–563. https://doi.org/10.1016/j.ccr.2004.10.011
Watkins S, Robel S, Kimbrough IF, Robert SM, Ellis-Davies G, Sontheimer H (2014) Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun 5:4196. https://doi.org/10.1038/ncomms5196
Cuddapah VA, Robel S, Watkins S, Sontheimer H (2014) A neurocentric perspective on glioma invasion. Nat Rev Neurosci 15(7):455–465. https://doi.org/10.1038/nrn3765
Bikfalvi A, Moenner M, Javerzat S, North S, Hagedorn M (2011) Inhibition of angiogenesis and the angiogenesis/invasion shift. Biochem Soc Trans 39(6):1560–1564. https://doi.org/10.1042/BST20110710
Scherer HJ (1938) Structural development in gliomas. Am J Cancer 34:333–351
Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, Sakariassen PO, Eskilsson E, Stieber D, Keunen O, Brekka N, Moen I, Nigro JM, Vintermyr OK, Lund-Johansen M, Niclou S, Mork SJ, Enger PO, Bjerkvig R, Miletic H (2013) EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathol 125(5):683–698. https://doi.org/10.1007/s00401-013-1101-1
Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G (2012) VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 22(1):21–35. https://doi.org/10.1016/j.ccr.2012.05.037
Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh M, Magnin N, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M (2010) Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci U S A 107(35):15553–15558. https://doi.org/10.1073/pnas.0914072107
Boye K, Pujol N, D Alves I, Chen YP, Daubon T, Lee YZ, Dedieu S, Constantin M, Bello L, Rossi M, Bjerkvig R, Sue SC, Bikfalvi A, Billottet C (2017) The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors. Nat Commun 8(1):1571. https://doi.org/10.1038/s41467-017-01686-y
Montana V, Sontheimer H (2011) Bradykinin promotes the chemotactic invasion of primary brain tumors. J Neurosci 31(13):4858–4867. https://doi.org/10.1523/JNEUROSCI.3825-10.2011
Javerzat SGV, Bikfalvi A (2013) Balancing risks and benefits of anti-angiogenic drugs for malignant glioma. Future Neurol 8(2):159–174
Moussion C, Girard JP (2011) Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479(7374):542–546. https://doi.org/10.1038/nature10540
Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP (2011) Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 71(17):5678–5687. https://doi.org/10.1158/0008-5472.CAN-11-0431
Yao L, Sgadari C, Furuke K, Bloom ET, Teruya-Feldstein J, Tosato G (1999) Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 93(5):1612–1621
Martinet L, Garrido I, Girard JP (2012) Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer. Oncoimmunology 1(5):789–790. https://doi.org/10.4161/onci.19787
Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G (2017) Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med 9(385). https://doi.org/10.1126/scitranslmed.aak9679
Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7(9):987–989. https://doi.org/10.1038/nm0901-987
Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9(6):685–693. https://doi.org/10.1038/nm0603-685
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bikfalvi, A. (2017). The Situation Is More Complex Than Anticipated. In: A Brief History of Blood and Lymphatic Vessels. Springer, Cham. https://doi.org/10.1007/978-3-319-74376-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-74376-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74375-2
Online ISBN: 978-3-319-74376-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)